Pacira BioSciences
PCRX
PCRX
272 hedge funds and large institutions have $1.84B invested in Pacira BioSciences in 2022 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 95 increasing their positions, 93 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $2.67B → $1.84B (-$833M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
75% less call options, than puts
Call options by funds: $903K | Put options by funds: $3.58M
Holders
272
Holding in Top 10
2
Calls
$903K
Puts
$3.58M
Top Buyers
| 1 | +$26.4M | |
| 2 | +$11.6M | |
| 3 | +$10.3M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$8.4M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$6.12M |
Top Sellers
| 1 | -$34.6M | |
| 2 | -$18.9M | |
| 3 | -$14.8M | |
| 4 |
MIIM
Mesirow Institutional Investment Management
Chicago,
Illinois
|
-$11.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$11.6M |